/**/ document.writeln("\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
MarketsQuoteDepth/LIIChartsNewsHistorical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n
powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Astrazeneca (AZN) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 44.82\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n  \n\n -0.37\n\n (-0.82%)\n\n \n\n \n\n \n\n \n\n Volume: 1.3 m\n\n \n\n \n\n\n\n 4:01 PM EST Nov 20, 2009\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n
\n \n \n \n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n\n
\n After Hours: \n $ 44.6192 \n \n \n \n \n   \n -0.2008\n (-0.45%)\n \n \n \n Volume: 3.6 k\n \n \n \n4:12 PM EST Nov 20, 2009\n\n \n
\n
\n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
July 24,2009
\n \n
Close: \n 47.61\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
March 09,2009
\n \n
Close: \n 29.96\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n
\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
44.82
\n
\n\n \n \n \n
Change $
\n \n 0.37\n \n
\n
\n \n\n \n \n
Change %
\n\n \n 0.82%\n \n
\n
\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
44.51
\n
\n \n \n \n\n
Bid Size
100
\n
\n \n \n \n
Ask
N/A
\n\n
\n \n \n \n
Ask Size
0
\n
\n \n \n \n
Open
44.385
\n
\n \n \n \n
High
44.82
\n
\n\n \n \n \n
Low
44.36
\n
\n \n\n \n \n
Prev Close
45.19
\n
\n \n\n \n \n
Last Trade
11/20/09
\n
\n \n \n \n
Volume
1.3 m
\n
\n \n \n \n
\n
52 Wk Hi
47.61
\n
\n\n \n \n \n
52 Wk Low
29.96
\n
\n \n\n \n \n
Market Cap
64.9 b
\n
\n \n \n \n
Ex-Div Date
8/5/09
\n
\n \n \n \n \n \n\n
Div Rate
1.18
\n
\n \n \n \n
Yield
2.6328
\n\n
\n \n\n \n \n
Shares
1,448,000,000
\n
\n \n \n \n
EPS (TTM)
4.99
\n
\n \n \n \n\n
PE Ratio
9.00
\n
\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
New York Stock Exchange (NYE)
\n
\n
\n
\n
\n
\n \n
Exchange
NYE
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Astrazeneca\n\n \n\n  (AZN) \n\n \n\n \n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking &\nFinance
\n\n
Capital Gains
\n
Mergers &\nAcquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary\nFund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for AZN\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Nov 20, 2009
\n\n \n\n\n\n
7:47 PM\n\n\n\n U.S. Court of Appeals Upholds AstraZeneca AWP Settlement - PR Newswire
10:30 AM\n\n\n\n AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 19, 2009
\n\n \n\n\n\n
3:06 PM\n\n\n\n L'Ivey Centre for Health Innovation & Leadership accueillera la Conférence sur l'innovation en santé à l'échelle mondiale - CNW
12:20 PM\n\n\n\n Ivey Centre for Health Innovation & Leadership to Host Global Health Innovation Conference - CNW
2:00 AM\n\n\n\n AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 18, 2009
\n\n \n\n\n\n
5:09 PM\n\n\n\n Dispensary of Hope Partners with Leading Pharma Companies to Expand Prescription Medications Access to Tennesseans in Need - Business Wire
9:15 AM\n\n\n\n Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body - PR Newswire
8:45 AM\n\n\n\n Harte-Hanks and MedImmune Win Medical Marketing & Media Gold Award - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 17, 2009
\n\n \n\n\n\n
7:07 PM\n\n\n\n Une étude révèle une réduction de près de la moitié du risque de maladie cardiovasculaire chez les femmes - CNW
7:07 PM\n\n\n\n Study demonstrates risk of cardiovascular disease cut by nearly half among women - CNW
4:36 PM\n\n\n\n Video: Crestor(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of Jupiter Study - PR Newswire
4:00 PM\n\n\n\n Video: CRESTOR(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of JUPITER Study - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 16, 2009
\n\n \n\n\n\n
5:45 PM\n\n\n\n MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition - PR Newswire
5:00 PM\n\n\n\n Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Sun, Nov 15, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Video: Ticagrelor (BRILINTA(TM)) Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting: Patients with ST-Segment Elevation Myocardial Infarction and Planned Percutaneous Coronary Intervention (PCI) - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Nov 13, 2009
\n\n \n\n\n\n
9:21 AM\n\n\n\n LILLY (ELI) & COMPANY - Dr Steven Paul Retire from Lilly Exec VP Sci-Tech - PR Newswire
9:04 AM\n\n\n\n Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor - PR Newswire
9:04 AM\n\n\n\n Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor - CNW
9:00 AM\n\n\n\n Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 12, 2009
\n\n \n\n\n\n
4:04 PM\n\n\n\n Santé Canada approuve un nouveau traitement destiné aux adultes atteints de diabète de type 2 - CNW
\n\n More News for AZN >>
\n\n
\n\n
\n\n\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n\n DL+   Realtime BATS,  \n\n EOD   End Of Day,  \n\n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");